English
Kwality Pharmaceuticals Q4 Results
- BSE: 539997
- NSE: -
- ISIN: INE552U01010
- Sector: Biotechnology & Drugs
BSE
859.30
-9.80 (-1.13%)
-9.80 (-1.13%)Volume6.62 K
Updated: Fri 7 Nov, 2025 | 15:56:17
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Kwality Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 94.87 | 71.47 | 32.75% | 83.52 | 13.60% |
| Depreciation/ Amortization | 5.09 | 4.56 | 11.63% | 5.07 | 0.37% |
| Operating Income | 20.80 | 12.94 | 60.76% | 8.46 | 145.92% |
| Net Income | 14.49 | 8.53 | 69.86% | 4.45 | 225.81% |
| Other Operating Expenses Total | 16.32 | 17.11 | -4.66% | 16.32 | -0.05% |
| Net Income Before Taxes | 19.07 | 11.39 | 67.42% | 5.98 | 218.71% |
| Total Revenue | 115.68 | 84.41 | 37.05% | 91.98 | 25.77% |
| Selling/ General/ Admin Expenses Total | 12.68 | 11.07 | 14.56% | 9.00 | 40.93% |
| Diluted Normalized EPS | 14.01 | 8.21 | 70.64% | 9.50 | 47.48% |